WS (WS)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9, Altman Z 3.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency for WS is currently strained, evidenced by an ROIC of 9.2% that falls significantly short of the 14.5% cost of equity, resulting in a negative spread of -5.3%. This indicates value destruction where returns on deployed capital fail to cover the hurdle rate required by shareholders. While the DuPont components are not explicitly detailed beyond margin and growth figures, the net margin compression at 3.6% coincides with revenue contraction of -9.8%, suggesting operational headwinds rather than a leverage-driven ROE boost. Credit quality metrics present a mixed signal; an Altman Z-Score of 3.3 places the firm in the "grey zone" between safety and distress, yet the Beneish M-Score of -2.88 strongly suggests low earnings manipulation risk, which may support underlying asset integrity despite deteriorating fundamentals.
Valuation multiples reflect market skepticism regarding future trajectory, with a current P/E of 12.0x likely priced against the backdrop of negative revenue growth and capital inefficiency. Although this multiple appears compressed relative to historical norms for profitable firms, it must be viewed through the lens of the DCF fair value estimate of $42, which implies that current market pricing may not fully account for potential mean reversion in margins or a stabilization in top-line performance if leverage is adjusted favorably. The disconnect between the negative ROIC-WACC spread and the available valuation discount suggests the stock carries significant downside risk absent a structural turnaround in operating efficiency.
Risk assessment highlights a precarious balance sheet profile given the Altman Z-Score proximity to distress thresholds, even as insider activity data remains unspecified in this dataset. The combination of shrinking revenues and capital destruction creates a high-beta environment where traditional value metrics may lag until operational leverage improves or debt levels are optimized. Investors must weigh whether the low Beneish M-Score provides sufficient confidence in reported earnings quality enough to justify holding through the current period of negative spread, or if the fundamental deterioration warrants caution regardless of valuation attractiveness.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 12.5% | 14.5% | 16.5% |
|---|---|---|---|
| 2% | $48 | $39 | $33 |
| 3% | $52 | $42 | $35 |
| 4% | $56 | $45 | $37 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=14.5%, terminal growth 3%. Fair value $42 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XME or SLYV, the fund manager is mechanically forced to buy or sell WS shares regardless of WS's individual fundamentals. We estimate $57M of passive capital is structurally linked to WS through 5 tracked ETFs. Passive flows have a limited but growing influence on WS's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 5 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in WS to visualize passive redemption contagion across ETFs and collateral stocks.
If WS (WS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Linde plc (LIN) as the most exposed collateral stock, sharing 1 ETFs with WS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 5 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
WS Ownership Dynamics
ETFs with Highest WS Exposure
Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
WS Capital Efficiency
How efficiently does WS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
WS converts 45% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 55% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-5.3%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-08 | 9,920 | $40.43 | $401,065.6 |
| 2026-04-30 | 5 | $36.40 | $182 |
| 2026-04-28 | 1,632 | $37.71 | $61,542.72 |
| 2026-04-09 | 865 | $33.51 | $28,986.15 |
| 2026-03-13 | 901 | $32.68 | $29,444.68 |
| 2026-03-05 | 257 | $39.08 | $10,043.56 |
| 2026-02-20 | 950 | $43.56 | $41,382 |
| 2026-02-19 | 3 | $43.98 | $131.94 |
| 2026-02-06 | 58 | $45.83 | $2,658.14 |
| 2026-02-04 | 2,792 | $44.41 | $123,992.72 |
| 2026-01-27 | 1,550 | $38.72 | $60,016 |
| 2026-01-02 | 63 | $34.62 | $2,181.06 |
| 2025-12-31 | 31 | $35.45 | $1,098.95 |
| 2025-12-16 | 1,632 | $35.45 | $57,854.4 |
| 2025-12-04 | 1,197 | $36.43 | $43,606.71 |
| 2025-12-01 | 640 | $33.75 | $21,600 |
| 2025-11-17 | 5,352 | $31.67 | $169,497.84 |
| 2025-11-14 | 10,458 | $31.77 | $332,250.66 |
| 2025-11-06 | 68 | $31.68 | $2,154.24 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare WS to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.